FDA Investigator

Alanna L Mussawwir Bias

Latest inspection on record: Aurangabad, India, April 2026 · records back to 2008

Human DrugsBiologicsMedical Devices & Rad HealthFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 148 inspections across 146 sites are on record.
  • 113 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-30.

At a glance

Inspections

148

Sites

146

Observations

113

Career since

Feb 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Dr. Manik Changoji Bhise, M.D.30 Apr 2026Human Drugs
Vennela Venkata Naidu, MBBS10 Apr 2026Human Drugs
Dr. Nagaraju Boyilla, M.D.28 Mar 2026Human DrugsOn file
Dr. Shuvra Neel Baul, MBBS, M.D., DM6 Mar 2026Human Drugs
Kurakula Srinivas, M.B.B.S.6 Feb 2026Human Drugs

Sites inspected

Dr. Manik Changoji Bhise, M.D.Aurangabad, India1 insp.
Vennela Venkata Naidu, MBBSVisakhapatnam, India1 insp.
Dr. Nagaraju Boyilla, M.D.Hyderabad, India1 insp.
Dr. Shuvra Neel Baul, MBBS, M.D., DMKolkata, India1 insp.
Kurakula Srinivas, M.B.B.S.Gajuwaka, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Kerun Hardeo2 shared
Rebecca T Davis2 shared
Ni A Khin2 shared
Simona M Bancos1 shared
Annabelle Crusan1 shared
Mark J Seaton1 shared
Zhou Chen1 shared
Hugh M Mcclure1 shared

Full investigator report

Get the verbatim findings behind Alanna L Mussawwir Bias' 113 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators